Adverse event profiles of CDK4/6 inhibitors: a disproportionality analysis of the FDA Adverse Event Reporting System (FAERS) database

Authors

Institutions

Publication Details

Journal
Expert Opinion on Drug Safety
Published
2025-02-20
DOI
https://doi.org/10.1080/14740338.2025.2465852
Citations
1
Primary Topic
Advanced Breast Cancer Therapies
Type
article
Field-Weighted Citation Impact
1.52
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Adverse event profiles of CDK4/6 inhibitors: a disproportionality analysis of the FDA Adverse Event Reporting System (FAERS) database

Lin Chen, Yonghong Chen, Xiaojiang Tian, Ni Zhang
1 citations
Expert Opinion on Drug Safety
Advanced Breast Cancer Therapies
1.52
article

Adverse event profiles of CDK4/6 inhibitors: a disproportionality analysis of the FDA Adverse Event Reporting System (FAERS) database

Lin Chen, Yonghong Chen, Xiaojiang Tian, Ni Zhang
article en
1 citations

Abstract

No abstract available for this paper.
Expert Opinion on Drug Safety
Dalian Medical University (CN), Second Affiliated Hospital of Chongqing Medical University (CN), Chongqing Maternal and Child Health Hospital (CN), Children's Hospital of Chongqing Medical University (CN), Chongqing Medical University (CN)
Openalex Percentile: Top 22%
Advanced Breast Cancer Therapies
1.52
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.